Business Wire

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc....

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages General Motors Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – GM

NEW YORK--(BUSINESS WIRE)--$GM #GM--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of General Motors...